Navigation Links
Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University

CLEVELAND, April 9 /PRNewswire/ -- Francis S. Collins, M.D., Ph.D. a physician-geneticist and leader of the Human Genome Project, has been named recipient of the inaugural Inamori Ethics Prize from the Inamori International Center for Ethics and Excellence at Case Western Reserve University.

(Photo: )

The Inamori Ethics Prize honors outstanding international ethical leaders. It is presented annually to an individual who has demonstrated exemplary ethical leadership and whose actions and influence have greatly improved the condition of humankind. The Inamori Ethics Prize carries with it a $25,000 cash award, intended to support the ongoing work of the Prize recipient.

A ceremony recognizing Collins will be held in conjunction with an ethics and genetics symposium and lecture September 4, 2008 at Severance Hall, on the Case Western Reserve campus.

"Dr. Collins' reputation as a principled leader of the Human Genome Project and the understanding that the Human Genome Project holds enormous potential for the improvement of humankind, make him an ideal recipient of the first Inamori Ethics Prize," said Gregory L. Eastwood, M.D., director of the Inamori Center.

Noted for his landmark discoveries of disease genes, Collins serves as director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH). His laboratory is dedicated to researching both rare and common diseases and has discovered a number of important genes, including those responsible for cystic fibrosis, neurofibromatosis, Huntington's disease, adult onset diabetes and Hutchinson-Gilford progeria syndrome, a dramatic form of premature aging.

Collins led the multi-disciplinary, multi-institutional Human Genome Project, an international effort to map and sequence the three billion letters in the human DNA, offering the first complete view of the "human instruction book." With its ultimate goal of improving human health, many consider the project to be one of the most significant scientific undertakings of our time. All the groundbreaking data are now available to the scientific community without restrictions on access or use.

Since the project's culmination in 2003, Collins has directed NHGRI's efforts to ensure that the important genetic data contained within the book are translated into powerful tools and thoughtful strategies to advance biological knowledge and improve human health.

Collins aims to open avenues for genome research to benefit the health of people living in developing nations, building on his own experiences as a physician volunteer in a rural missionary hospital in Nigeria.

"Throughout his long and distinguished career, Dr. Collins has consistently emphasized the importance of ethical and legal issues in genetics, while at the same time working tirelessly to improving the lives of people worldwide," said Eastwood.

According to the NHGRI, its supported initiatives currently include efforts to map human genetic variation, to develop less costly sequencing technologies and to unravel the genetics of cancer and other common diseases. Following the precedent set by the Human Genome Project under Collins' leadership, these projects are committed to making their data rapidly and freely available to the worldwide scientific community.

His book, "The Language of God: A Scientist Presents Evidence for Belief" (Free Press, 2006), which broaches the interface between science and faith, spent several weeks on The New York Times bestseller's list.

Collins received a bachelor's degree in chemistry from the University of Virginia, a Ph.D. in physical chemistry from Yale University and his M.D. from the University of North Carolina. After an internal medicine residency at UNC and a genetics fellowship at Yale, he joined the faculty at the University of Michigan School of Medicine. He was appointed director of the National Center for Human Genome Research at NIH in 1993.

A member of the Institute of Medicine and the National Academy of Sciences. Collins has nearly 400 scientific publications in peer-reviewed journals, has received nine honorary degrees and in November 2007 was a recipient of the Presidential Medal of Freedom.

About Case Western Reserve University

Case Western Reserve is among the nation's leading research institutions. Founded in 1826 and shaped by the unique merger of the Case Institute of Technology and Western Reserve University, Case Western Reserve is distinguished by its strengths in education, research, service, and experiential learning. Located in Cleveland, Case Western Reserve offers nationally recognized programs in the Arts and Sciences, Dental Medicine, Engineering, Law, Management, Medicine, Nursing, and Social Work. .

About the Inamori International Center for Ethics and Excellence

The purpose of the Inamori Center is to foster ethical leadership around the world. The Inamori Center fulfills its purpose by awarding the high profile Inamori Ethics Prize annually, collaborating with people and programs at Case Western Reserve University and around the world, and sponsoring ethics research, scholarship, symposia, lectures, and other means of ethical discourse.

The Inamori Center began in July 2006 as the result of a generous gift from Kazuo Inamori, founder of the Kyocera Corporation. Dr. Inamori, founder of the Kyocera Corporation, believes that "the future of humanity can be assured only through the balance of scientific progress and spiritual maturity." The center is charged with creating internationally recognized programs and initiatives devoted to ethical inquiry in both its practical and theoretical aspects, and to facilitating the development of future leaders who will, in the words of Dr. Inamori, "serve humankind through ethical deeds rather than actions based on self-interest and selfish desires."

SOURCE Case Western Reserve University
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
3. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
4. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
7. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium
10. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
11. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
Post Your Comments:
(Date:11/27/2015)... Kingdom , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... company, announced today that it has closed the sale ... business to Guerbet (GBT- NYSE Euronext) in a transaction ... encompassed four manufacturing facilities and a total of approximately ... in the St. Louis area. ...
(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... a biotechnology company developing bioengineered organ implants for life-threatening ... will present at the LD Micro "Main Event" investor ... PT. The presentation will be webcast live and posted ... also be available at the conference for one-on-one meetings ...
Breaking Biology Technology:
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
(Date:10/29/2015)... OXFORD, Connecticut , October 29, 2015 /PRNewswire/ ... "Company"), a biometric authentication company focused on the ... Wocket® smart wallet announces that StackCommerce, a leading ... will be featuring the Wocket® smart wallet on ... NXTD ) ("NXT-ID" or the "Company"), a ...
Breaking Biology News(10 mins):